Anticoagulation in Patients with End-Stage Renal Disease and Atrial Fibrillation: Confusion, Concerns and Consequences

키워드

참고문헌 (65)

1. "2019 USRDS annual data report: epidemiology of kidney disease in the United States" (2019)[URL]
2. "2018 USRDS annual data report: Epidemiology of kidney disease in the United States" (2018)[URL]
3. Buiten MS, "The dialysis procedure as a trigger for atrial fibrillation : new insights in the development of atrial fibrillation in dialysis patients", Heart, 100, pp.685~690 (2014)
4. Abuhasira R, "Atrial fibrillation characteristics in patients on haemodialysis vs. peritoneal dialysis", Sci Rep, 8, pp.2976~ (2018)
5. Olesen JB, "Stroke and bleeding in atrial fibrillation with chronic kidney disease", N Engl J Med, 367, pp.625~635 (2012)
6. Wanner C, "Chronic kidney disease and arrhythmias: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference", Kidney Int, 94, pp.231~234 (2018)
7. Potpara TS, "Management of atrial fibrillation in patients with chronic kidney disease in clinical practice : a joint European Heart Rhythm Association(EHRA)and European Renal Association", European Dialysis and Transplantation Association(ERA, Europace, pp.2020, 22[DOI]
8. Chang CH, "Atrial fibrillation and associated outcomes in patients with peritoneal dialysis and hemodialysis : a 14-year nationwide population-based study", J Nephrol (2020)[DOI]
9. Findlay M, "The association of atrial fibrillation and ischemic stroke in patients on hemodialysis : a competing risk analysis", Can J Kidney Health Dis, 6, pp.2054358119878719~ (2019)
10. Waddy SP, "Racial", ethnic disparities in atrial fibrillation treatment and outcomes among dialysis patients in the United States, 2020, pp.31, 637~649
11. Wetmore JB, "Relationship between stroke and mortality in dialysis patients", Clin J Am Soc Nephrol, 10, pp.80~89 (2015)
12. Wang HH, "Risk of stroke in long-term dialysis patients compared with the general population", Am J Kidney Dis, 63, pp.604~611 (2014)
13. Malyszko J, "Atrial fibrillation in kidney transplant recipients: is there a place for the novel drugs?", Nephrol Dial Transplant, 33, pp.1304~1309 (2018)
14. Bansal N, "Atrial fibrillation and risk of ESRD in adults with CKD", Clin J Am Soc Nephrol, 11, pp.1189~1196 (2016)
15. Bansal N, "Cardiovascular events after new-onset atrial fibrillation in adults with CKD : results from the Chronic Renal Insufficiency Cohort(CRIC)study", J Am Soc Nephrol, 29, pp.2859~2869 (2018)
16. Hsu HH, "Effects of prevalent and incident atrial fibrillation on renal outcome, cardiovascular events, and mortality in patients with chronic kidney disease", J Clin Med, 8, pp.1378~ (2019)
17. Tanaka A, "Presence of atrial fibrillation at the time of dialysis initiation is associated with mortality and cardiovascular events", Nephron, 132, pp.86~92 (2016)
18. Korantzopoulos PG, "Atrial fibrillation in endstage renal disease : an emerging problem", Kidney Int, 76, pp.247~249 (2009)
19. Chai C, "Increased number and distribution of cerebral microbleeds is a risk factor for cognitive dysfunction in hemodialysis patients:a longitudinal study", Medicine (Baltimore), 95, pp.e2974~ (2016)
20. Lau WL, "Chronic kidney disease increases cerebral microbleeds in mouse and man", Transl Stroke Res, 11, pp.122~134 (2020)
21. Cho AH, "Impaired kidney function and cerebral microbleeds in patients with acute ischemic stroke", Neurology, 73, pp.1645~1648 (2009)
22. Song TJ, "Association of cerebral microbleeds with mortality in stroke patients having atrial fibrillation", Neurology, 83, pp.1308~1315 (2014)
23. Charidimou A, "Brain microbleeds, anticoagulation, and hemorrhage risk: meta-analysis in stroke patients with AF", Neurology, 89, pp.2317~2326 (2017)
24. Lu HY, "Increased risk of deep vein thrombosis in end-stage renal disease patients", BMC Nephrol, 19, pp.204~ (2018)
25. Gäckler A, "Evaluation of hemostasis in patients with end-stage renal disease", PLoS One, 14, pp.e0212237~ (2019)
26. Jain D, "Choice of dialysis modality prior to kidney transplantation: does it matter?", World J Nephrol, 8, pp.1~10 (2019)
27. Parajuli S, "Hypercoagulability in kidney transplant recipients", Transplantation, 100, pp.719~726 (2016)
28. Mohapatra A, "Hemostatic abnormalities in severe renal failure: do they bark or bite?", Indian J Nephrol, 28, pp.135~142 (2018)
29. Aursulesei V, "Anticoagulation in chronic kidney disease : from guidelines to clinical practice", Clin Cardiol, 42, pp.774~782 (2019)
30. Lutz J, "Haemostasis in chronic kidney disease", Nephrol Dial Transplant, 29, pp.29~40 (2014)
31. Kaw D, "Platelet dysfunction and end-stage renal disease", Semin Dial, 19, pp.317~322 (2006)
32. Chao TF, "Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis", Heart Rhythm, 11, pp.1752~1759 (2014)
33. Wetmore JB, "Atrial fibrillation and risk of stroke in dialysis patients", Ann Epidemiol, 23, pp.112~118 (2013)
34. Alqahtani F, "Temporal trends in the outcomes of dialysis patients admitted with acute ischemic stroke", J Am Heart Assoc, 7, pp.e008686~ (2018)
35. Gerson LB, "Causes of gastrointestinal hemorrhage in patients with chronic renal failure", Gastroenterology, 145, pp.895~897 (2013)
36. Hágendorn R, "Chronic kidney disease severely deteriorates the outcome of gastrointestinal bleeding : a meta-analysis", World J Gastroenterol, 23, pp.8415~8425 (2017)
37. Wang IK, "Comparison of subdural hematoma risk between hemodialysis and peritoneal dialysis patients with ESRD", Clin J Am Soc Nephrol, 10, pp.994~1001 (2015)
38. Sood MM, "Risk of major hemorrhage after kidney transplantation", Am J Nephrol, 41, pp.73~80 (2015)
39. Holden RM, "Major bleeding in hemodialysis patients", Clin J Am Soc Nephrol, 3, pp.105~110 (2008)
40. Oladiran O, "Stroke risk stratification in atrial fibrillation : a review of common risk factors", J Community Hosp Intern Med Perspect, 9, pp.113~120 (2019)
41. Fox KAA, "Improved risk stratification of patients with atrial fibrillation : an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation", BMJ Open, 7, pp.e017157~ (2017)
42. Proietti M, "Comparison of bleeding risk scores in patients with atrial fibrillation : insights from the RE-LY trial", J Intern Med, 283, pp.282~292 (2018)
43. Chen CY, "Effectiveness and safety of antiplatelet in stroke patients with end-stage renal disease undergoing dialysis", Int J Stroke, 9, pp.580~590 (2014)
44. Bonde AN, "Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease : a nationwide observational cohort study", J Am Coll Cardiol, 64, pp.2471~2482 (2014)
45. Daimon S, "Influence of antiplatelet medications on bleeding events in hemodialysis patients", Ther Apher Dial, 15, pp.454~459 (2011)
46. Aoun M, "Reduction of intracerebral hemorrhage in hemodialysis patients after reducing aspirin use : a quality-assurance observational study", PLoS One, 12, pp.e0185847~ (2017)
47. Lemos Cerqueira T, "The use of aspirin to reduce the risk of thrombotic events in patients with endstage renal disease : protocol for a randomized controlled trial", JMIR Res Protoc, 7, pp.e10516~ (2018)
48. Harel Z, "Warfarin and the risk of stroke and bleeding in patients with atrial fibrillation receiving dialysis : a systematic review and meta-analysis", Can J Cardiol, 33, pp.737~746 (2017)
49. Tan J, "Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis", BMC Nephrol, 17, pp.157~ (2016)
50. Van Der Meersch H, "Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation : a systematic review and meta-analysis", Am Heart J, 184, pp.37~46 (2017)
51. Lenihan CR, "Correlates and outcomes of warfarin initiation in kidney transplant recipients newly diagnosed with atrial fibrillation", Nephrol Dial Transplant, 30, pp.321~329 (2015)
52. Mookadam M, "Novel anticoagulants in atrial fibrillation : a primer for the primary physician", J Am Board Fam Med, 28, pp.510~522 (2015)
53. "Xarelto (rivaroxaban) prescribing information: package insert" (2020)[URL]
54. "Eliquis (apixaban) prescribing information: package insert" (2019)[URL]
55. Mavrakanas TA, "Apixaban pharmacokinetics at steady state in hemodialysis patients", J Am Soc Nephrol, 28, pp.2241~2248 (2017)
56. Wang X, "Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis", J Clin Pharmacol, 56, pp.628~636 (2016)
57. Siontis KC, "Outcomes associated with apixaban use in patients with end-stage kidney disease and atrial fibrillation in the United States", Circulation, 138, pp.1519~1529 (2018)
58. Chokesuwattanaskul R, "Safety and efficacy of apixaban versus warfarin in patients with endstage renal disease : meta-analysis", Pacing Clin Electrophysiol, 41, pp.627~634 (2018)
59. Kuno T, "Oral anticoagulation for patients with atrial fibrillation on long-term hemodialysis", J Am Coll Cardiol, 75, pp.273~285 (2020)
60. Steuber TD, "A multicenter analysis of factors associated with apixabanrelated bleeding in hospitalized patients with end-stage renal disease on hemodialysis", Ann Pharmacother, 51, pp.954~960 (2017)
61. Shah M, "Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis", Circulation, 129, pp.1196~1203 (2014)
62. Kai B, "Warfarin use and the risk of mortality, stroke, and bleeding in hemodialysis patients with atrial fibrillation", Heart Rhythm, 14, pp.645~651 (2017)
63. Shen JI, "Outcomes after warfarin initiation in a cohort of hemodialysis patients with newly diagnosed atrial fibrillation", Am J Kidney Dis, 66, pp.677~688 (2015)
64. Yoon CY, "Warfarin use in patients with atrial fibrillation undergoing hemodialysis : a nationwide population-based study", Stroke, 48, pp.2472~2479 (2017)
65. Mavrakanas TA, "Apixaban versus no anticoagulation in patients undergoing long-term dialysis with incident atrial fibrillation", Clin J Am Soc Nephrol, 15, pp.1146~1154 (2020)

관련 논문AI추천